Global Normal Saline for Parenteral Use Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Normal Saline for Parenteral Use Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Normal Saline belongs to a class of drugs called Crystalloid Fluid. Normal saline is used extensively in hospitals for a wide range of conditions such as dehydration, electrolyte imbalance, wound dressing, sepsis, hemorrhage, and others. This report is about Normal Saline for Parenteral Use.

Market Overview:

The latest research study on the global Normal Saline for Parenteral Use market finds that the global Normal Saline for Parenteral Use market reached a value of USD 3009.96 million in 2022. It’s expected that the market will achieve USD 4103.93 million by 2028, exhibiting a CAGR of 5.3% during the forecast period.

Normal Saline for Parenteral Use Market Challenges

Various studies have shown that using balanced IV fluids instead of saline reduces the risk of death and kidney damage significantly among hospitalized patients. One such study estimated that switching from saline to balanced IV fluids can result in around 60,000 fewer deaths and 100,000 fewer cases of kidney failure in the U.S. Another study conducted by Vanderbilt University concluded that for every 100 hospitalized patients that were given balanced fluids instead of saline, there was one fewer death or severe kidney problem, which is a huge impact in the context of over 35 million hospitalizations that happen in the U.S. annually.

The usage of balanced fluids in healthcare facilities in Europe and Australia have also increased due to the growing awareness about the harm saline can do to a patient's kidneys. Usage of saline in the public healthcare system in Australia reduced from 7.4 million liters in 2013 to 7.3 million liters in 2014 even when the number of patient admissions to public hospitals has been growing by 3-4% annually. Thus, the gradual shift towards balanced fluids is anticipated to hamper the market growth.

Region Overview:

From 2023-2028, Asia Pacific is estimated to witness robust growth prospects.

Company Overview:

The top three companies are Baxter, B. Braun, Kelun Group with the revenue market share of 12.58%, 9.50%, 8.39% in 2021.

Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions.

B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry.

Segmentation Overview:

Among different product types, Flexible Bag segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Hospital segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Normal Saline for Parenteral Use market covered in Chapter 3:

Otsuka
ICU Medical
B. Braun
Kelun Group
Denis Chem Lab
Fresenius Kabi
Grifols
CR Double-Crane
Baxter
SSY Group
Shree Krishnakeshav Laboratories
Cisen Pharmaceutical

In Chapter 4 and Chapter 14.2, on the basis of types, the Normal Saline for Parenteral Use market from 2018 to 2029 is primarily split into:

Flexible Bag
Plastic Bottles
Glass Bottles

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Normal Saline for Parenteral Use market from 2018 to 2029 covers:

Hospital
Clinics
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)